Amlodipin/Valsartan Genericon 5 mg/160 mg filmom obložene tablete Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

amlodipin/valsartan genericon 5 mg/160 mg filmom obložene tablete

genericon pharma gesellschaft m.b.h., hafnerstraße 211, graz, austrija - amlodipinbesilat valsartan - filmom obložena tableta - 5 mg + 160 mg - urbroj: jedna filmom obložena tableta sadrži 5 mg amlodipina (u obliku amlodipinbesilata) i 160 mg valsartana

Amlodipin/Valsartan Genericon 10 mg/160 mg filmom obložene tablete Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

amlodipin/valsartan genericon 10 mg/160 mg filmom obložene tablete

genericon pharma gesellschaft m.b.h., hafnerstraße 211, graz, austrija - amlodipinbesilat valsartan - filmom obložena tableta - 10 mg + 160 mg - urbroj: jedna filmom obložena tableta sadrži 10 mg amlodipina (u obliku amlodipinbesilata) i 160 mg valsartana

Amlodipin/Valsartan Genericon 5 mg/80 mg filmom obložene tablete Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

amlodipin/valsartan genericon 5 mg/80 mg filmom obložene tablete

genericon pharma gesellschaft m.b.h., hafnerstraße 211, graz, austrija - amlodipinbesilat valsartan - filmom obložena tableta - 5 mg + 80 mg - urbroj: jedna filmom obložena tableta sadrži 5 mg amlodipina (u obliku amlodipinbesilata) i 80 mg valsartana

Spikevax (previously COVID-19 Vaccine Moderna) Europska Unija - hrvatski - EMA (European Medicines Agency)

spikevax (previously covid-19 vaccine moderna)

moderna biotech spain, s.l. - single-stranded, 5’-capped messenger rna (mrna) produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - cjepiva - spikevax is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax bivalent original/omicron ba. 1 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against covid-19. spikevax bivalent original/omicron ba. 4-5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older.  spikevax xbb. 5 is indicated for active immunisation to prevent covid 19 caused by sars-cov-2 in individuals 6 months of age and older. the use of this vaccine should be in accordance with official recommendations.